Cargando…

Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR(2)) knockout mice

BACKGROUND: In this study we used radiotelemetry to measure hemodynamic variables and locomotor activity in conscious unrestrained male Protease-Activated Receptor 2 (PAR-2) knockout mice in order to provide a detailed assessment of their blood pressure phenotype. In addition we tested for an influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGuire, John J, Van Vliet, Bruce N, Halfyard, Sarah J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2573878/ https://www.ncbi.nlm.nih.gov/pubmed/18939990 http://dx.doi.org/10.1186/1472-6793-8-20

Ejemplares similares

Attenuated Vasodilator Effectiveness of Protease-Activated Receptor 2 Agonist in Heterozygous par2 Knockout Mice
por: Hennessey, John C., et al.
Publicado: (2013)

Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice
por: Chia, Elizabeth, et al.
Publicado: (2011)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice
por: Kagota, Satomi, et al.
Publicado: (2011)

Predictive value of protease‐activated receptor‐2 (PAR(2)) in cervical cancer metastasis
por: He, Shengnan, et al.
Publicado: (2020)

Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review
por: Kagota, Satomi, et al.
Publicado: (2016)

Chemical Tools to Image the Activity of PAR-Cleaving Proteases
por: Lee, Irene Y., et al.
Publicado: (2023)

Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells
por: Suen, Jacky Y., et al.
Publicado: (2010)

Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats
por: Ryuzaki, Masaki, et al.
Publicado: (2022)

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy
por: Ocasio-Rivera, Marinel, et al.
Publicado: (2020)

A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH(2), induces protease release from mast cells: role in TNF degradation
por: Alshurafa, Hashem N, et al.
Publicado: (2004)

Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis
por: Huang, Xiaojian, et al.
Publicado: (2019)

Knockout of Angiotensin AT(2) receptors accelerates healing but impairs quality
por: Faghih, Mahya, et al.
Publicado: (2015)

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015)

Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression
por: Rossetti, Clara, et al.
Publicado: (2017)

Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR(2)) through the Use of Lipid Tethering
por: Boitano, Scott, et al.
Publicado: (2014)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Anti-SARS-CoV-2 Activity of Surgical Masks Infused with Quaternary Ammonium Salts
por: Selwyn, Gary S., et al.
Publicado: (2021)

Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity
por: Price, Rachel, et al.
Publicado: (2021)

Candida albicans Sap6 Initiates Oral Mucosal Inflammation via the Protease Activated Receptor PAR2
por: Kumar, Rohitashw, et al.
Publicado: (2022)

Small caliber arterial endothelial cells calcium signals elicited by PAR2 are preserved from endothelial dysfunction
por: Hennessey, John C, et al.
Publicado: (2015)

C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice
por: Kume, Moeno, et al.
Publicado: (2023)

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
por: French, Shauna L., et al.
Publicado: (2016)

Protease-Activated Receptor (PAR)2, but Not PAR1, Is Involved in Collateral Formation and Anti-Inflammatory Monocyte Polarization in a Mouse Hind Limb Ischemia Model
por: van den Hengel, Lisa G., et al.
Publicado: (2013)

Panic disorder and locomotor activity
por: Sakamoto, Noriyuki, et al.
Publicado: (2008)

Effects of Cannabidiol on Locomotor Activity
por: Calapai, Fabrizio, et al.
Publicado: (2022)

A high-salt/high fat diet alters circadian locomotor activity and glucocorticoid synthesis in mice
por: Yokoyama, Yoko, et al.
Publicado: (2020)

Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2013)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
por: Rwibasira Rudinga, Gamariel, et al.
Publicado: (2018)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis
por: Nakahara, Kozue, et al.
Publicado: (2019)

Anxiolytic-Like Effects and Increase in Locomotor Activity Induced by Infusions of NMDA into the Ventral Hippocampus in Rat: Interaction with GABAergic System
por: Bina, Payvand, et al.
Publicado: (2014)

A6 PROTEASE-ACTIVATED RECEPTOR (PAR)-2 ACTIVATION ENHANCES EPITHELIAL WOUND HEALING MIGRATION THROUGH SRC AND RAC1 PATHWAYS
por: Lucena Perico, L, et al.
Publicado: (2023)

Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury
por: Whetstone, William D., et al.
Publicado: (2017)

Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells
por: Ni, Jie, et al.
Publicado: (2013)

Correction: Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gfakpldfquedajv0n19q50cjud